Literature DB >> 7828455

Pharmacokinetics of dexamethasone following single-dose intravenous administration to extremely low birth weight infants.

B Charles1, P Schild, P Steer, D Cartwright, T Donovan.   

Abstract

The single-dose pharmacokinetics of dexamethasone were studied in 7 extremely low birth weight infants of mean (+/- SD) gestational age 25.6 +/- 0.5 weeks suffering bronchopulmonary dysplasia. A mean peak dexamethasone concentration of 250.5 +/- 70.7 ng/ml was obtained following an intravenous bolus dose (0.369 +/- 0.04 mg/kg dexamethasone) of dexamethasone sodium phosphate. Dexamethasone was measured in plasma by HPLC. Mean clearance (0.143 +/- 0.028 litres/kg/h) was approximately half that reported previously in children and adults, while the half-life (9.26 +/- 3.34 h) was 2- to 3-fold longer than in these patients. The volume of distribution (1.9 +/- 0.483 litres/kg) was larger than reported in a previous study in adults, but was similar to that determined in pediatric and adult patients in another study.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7828455     DOI: 10.1159/000457564

Source DB:  PubMed          Journal:  Dev Pharmacol Ther        ISSN: 0379-8305


  6 in total

1.  Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants.

Authors:  Ann R Stark; Waldemar A Carlo; Betty R Vohr; Lu Ann Papile; Shampa Saha; Charles R Bauer; William Oh; Seetha Shankaran; Jon E Tyson; Linda L Wright; W Kenneth Poole; Abhik Das; Barbara J Stoll; Avroy A Fanaroff; Sheldon B Korones; Richard A Ehrenkranz; David K Stevenson; Myriam Peralta-Carcelen; Deanne E Wilson-Costello; Henrietta S Bada; Roy J Heyne; Yvette R Johnson; Kimberly Gronsman Lee; Jean J Steichen
Journal:  J Pediatr       Date:  2013-08-27       Impact factor: 4.406

2.  Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.

Authors: 
Journal:  Paediatr Child Health       Date:  2002-01       Impact factor: 2.253

3.  Pharmacokinetics of dexamethasone in premature neonates.

Authors:  R A Lugo; M C Nahata; J A Menke; R E McClead
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

4.  Chlorpyrifos developmental neurotoxicity: interaction with glucocorticoids in PC12 cells.

Authors:  Theodore A Slotkin; Jennifer Card; Frederic J Seidler
Journal:  Neurotoxicol Teratol       Date:  2012-07-14       Impact factor: 3.763

5.  Across-species meta-analysis of dexamethasone pharmacokinetics utilizing allometric and scaling modeling approaches.

Authors:  Dawei Song; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2021-03-17       Impact factor: 1.627

6.  Activation of coagulation by lenalidomide-based regimens for the treatment of multiple myeloma.

Authors:  Yu Isozumi; Reina Arai; Kazumi Fujimoto; Takatoshi Koyama
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.